Shares of Avalo Therapeutics, Inc. (AVTX) are soaring over 260% on Thursday after the biotech company announced the acquisition of a Phase 2-ready anti-IL-1ß mAb developed for a chronic inflammatory skin condition, through the acquisition of privately held AlmataBio, Inc.
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Zura Bio (ZURA) Appoints Arnout Ploos van Amstel to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
WAYNE, Pa. and ROCKVILLE, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) In a major achievement, Avalo Therapeutics (NASDAQ:AVTX) proudly announces the payoff of the remainder of its $35 million debt owed to Horizon